CoChat
Sign Up
Cited by 162Fatty Acid Research and HealthNutritional Studies and DietAdipokines, Inflammation, and Metabolic Diseases

The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.

The impact of long chain n ‐3 polyunsaturated fatty acid supplementation on inflammation, insulin sensitivity and CVD risk in a group of overweight women with an inflammatory phenotype

Browning, L. M., Krebs, J. D., Moore, C. S., Mishra, G. D., O’Connell, M. A., Jebb, S. A.·2007·Diabetes Obesity and Metabolism
DOI 10.1111/j.1463-1326.2006.00576.x
Open this paper in CoChat — free account

Abstract

BACKGROUND: Inflammation is strongly related to obesity and the risk of cardiovascular disease (CVD). The metabolic benefits of long chain (LC) n-3 polyunsaturated fatty acid (PUFA) may be attributable to its anti-inflammatory properties. OBJECTIVE: To investigate whether an individual's habitual inflammatory status influences the impact of a LC n-3 PUFA intervention on CVD risk. DESIGN: The study was a randomized crossover design. Subjects received LC n-3 PUFA capsules or a placebo for 12 weeks, with 4-week washout between phases. Thirty women, in the top and bottom tertiles of baseline sialic acid concentration, formed raised inflammatory status (top, n = 12) and reference (bottom, n = 18) groups. Baseline data were analysed using one-way anova, differences between treatment phases were calculated at each timepoint and analysed using a random effects model. RESULTS: At baseline, the raised inflammatory status group had significantly higher body mass index and area under the curve (AUC) insulin than the reference group. With LC n-3 PUFA supplementation, both groups showed significantly higher plasma eicosapentaenoic acid and docosahexaenoic acid at 4 and 12 weeks (p < 0.001), and lower triacylglycerols (4 weeks p < 0.01 and 12 weeks p < 0.05). The difference in AUC insulin between the two treatment phases at 12 weeks was significantly greater in the raised inflammatory status group compared to the reference group (p < 0.05). Inflammatory markers were significantly lower after 12 weeks LC n-3 PUFA supplementation compared to baseline (C-reactive protein p < 0.05 and interleukin-6 p < 0.01), but there was no significant group effect. CONCLUSIONS: Habitual inflammatory status influences the impact of LC n-3 PUFA supplementation, but it is not clear whether the effect of LC n-3 PUFA on AUC insulin is mediated through inflammatory mechanisms.

Overview

Integrity signals

Registry

Crossref · 10.1111/j.1463-1326.2006.00576.x

Cites

44 of 44 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Flagged first, then by citations

Show all 43 references

Research works printed but not linked: 1

  1. Krebs JD, 2002, Obesity, Inflammation and Insulin Resistance: Impact of Dietary Factors

Cited by

Sorted by citations

Items 101–162 of 162

Related

See all

Metadata

Authors
Browning, L. M., Krebs, J. D., Moore, C. S., Mishra, G. D., O’Connell, M. A., & Jebb, S. A.
Affiliations
MRC Elsie Widdowson Laboratory (GB)
Corresponding author
Browning, L. M.
ORCID
Venue
Diabetes Obesity and Metabolism
Publisher
Wiley
Published
2006-04-07
Volume
9
Issue
1
Pages
70-80
ISSN
  • 1462-8902 (ISSN-L)
  • 1463-1326
DOI
10.1111/j.1463-1326.2006.00576.x
OpenAlex
W2156679204
Cited by
162
References
43
Citations by year
2026: 3 · 2025: 6 · 2024: 1 · 2023: 3 · 2022: 1 · 2021: 8 · 2020: 5 · 2019: 6 · 2018: 5 · 2017: 6 · 2016: 12 · 2015: 8 · 2014: 18 · 2013: 13 · 2012: 12
FWCI
7.91
Type
journal article
Language
en
Open access
closed
Licence
onlinelibrary.wiley.com/termsAndConditions#vor (vor)
Locations
  • Diabetes Obesity and Metabolism (publishedVersion)
  • PubMed (publishedVersion)
  • UCL Discovery (University College London) (submittedVersion)
  • UEA Digital Repository (University of East Anglia) (submittedVersion)
Funders
Medical Research Council
Topics
  • Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Nutritional Studies and Diet
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
Keywords
n-3 long-chain polyunsaturated fatty acids, omega-3 supplementation, inflammation, insulin sensitivity, cardiovascular risk, overweight women, sialic acid, inflammatory phenotype, eicosapentaenoic acid, docosahexaenoic acid, C-reactive protein, interleukin-6, triglycerides, obesity
MeSH terms
Adult, Blood Glucose, C-Reactive Protein, Cardiovascular Diseases, Female, Humans, Inflammation, Insulin Resistance, Obesity, Phenotype, Fatty Acids, Omega-3, Treatment Outcome, Cross-Over Studies, Inflammation Mediators, N-Acetylneuraminic Acid, Dietary Supplements, Overweight

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review